Table 2.
Baseline demographic and clinical characteristics of participants with or without initial carotid atherosclerosis (CA)
| Non-CA (n = 2628) | CA (n = 1548) | P≤ | |
|---|---|---|---|
| Age (years) | 53.57 ± 8.9 | 62.37 ± 7.7 | 0.0001 |
| Sex (M/F %) | 56.2/43.8 | 60.9/39.1 | 0.004 |
| BMI (kg/m2) | 27.64 ± 4.1 | 27.62 ± 3.9 | 0.891 |
| Hypertension duration (years) | 5.03 ± 5.9 | 6.95 ± 7.2 | 0.0001 |
| Systolic BP (mmHg) | 140.92 ± 16.3 | 143.50 ± 18.0 | 0.0001 |
| Diastolic BP (mmHg) | 90.38 ± 10.0 | 89.21 ± 10.6 | 0.0001 |
| Heart rate (b.p.m.) | 74.87 ± 11.5 | 73.76 ± 11.5 | 0.002 |
| Fasting plasma glucose (mg/dL) | 93.27 ± 11.8 | 95.38 ± 12.4 | 0.0001 |
| HDL Cholesterol (mg/dL) | 50.51 ± 12.8 | 50.03 ± 12.3 | 0.233 |
| Triglycerides (mg/dL) | 131.0 ± 74.0 | 138.5 ± 74.2 | 0.001 |
| Metabolic syndrome (%) | 33.1 | 33.5 | 0.780 |
| Family history of diabetes (%) | 30.0 | 30.1 | 0.954 |
| CCB (%) | 20.4 | 26.0 | 0.0001 |
| β-Blockers (%) | 26.9 | 26.4 | 0.680 |
BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; CCB, calcium channel blockers.